Existing sepsis diagnostic methods typically require several days to allow the bacteria responsible for the infection to multiply to detectable levels in the blood sample.
“Our approach bypasses this step and identifies fungal and bacterial pathogens at the single-cell level,” Pak Kin Wong, PhD, professor at Penn State and co-principal research investigator said in the statement.
This method will also identify how resistant individual pathogens are to antibiotics, according to researchers.
More articles on patient safety:
Insurance type may affect quality of surgical care, study finds
Boston Children’s Hospital to end 2 intersex surgeries
Down syndrome linked to 10 times higher COVID-19 death risk, UK study finds
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
